Recruiting NA INTERVENTIONAL 2-arm NCT04883515

Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients. (OBEGLUT)

Sponsor: University Hospital, Rouen

Interventions Functional intestinal disorders evaluation Insulin-resistance evaluation Oral glutamine supplementation Oral protein powder supplementation

Updated 5 times since 2021 Last updated: Feb 5, 2026 Started: Mar 1, 2023 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Insulin Resistance and Obesity, this trial is actively recruiting participants. The trial is conducted by University Hospital, Rouen and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA

Status: Unknown → Recruiting
Oct 2024 — Feb 2026 [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jun 2021 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Rouen

Data source: University Hospital, Rouen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rouen, France